These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11213671)

  • 1. [Blood transfusion therapy at the Military Medicine Academy--present possibilities].
    Taseski J; Balint B; Radović M
    Vojnosanit Pregl; 2000; 57(5):17-27. PubMed ID: 11213671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood components: indication and notice of transfusion].
    Sekiguchi S
    Nihon Rinsho; 1997 Sep; 55(9):2205-13. PubMed ID: 9301278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Labile blood products and their preparation].
    Chabanel A; Folléa G
    Rev Prat; 2001 Jun; 51(12):1306-10. PubMed ID: 11503503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
    Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
    Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
    Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
    Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A program to limit donor exposures to neonates undergoing extracorporeal membrane oxygenation.
    Rosenberg EM; Chambers LA; Gunter JM; Good JA
    Pediatrics; 1994 Sep; 94(3):341-6. PubMed ID: 8065860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates.
    Weisbach V; Wanke C; Zingsem J; Zimmermann R; Eckstein R
    Vox Sang; 1999; 76(2):100-6. PubMed ID: 10085526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood banking and transfusion medicine for the nephrologist.
    Wehrli G
    Semin Dial; 2012; 25(2):114-8. PubMed ID: 22276991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions.
    Cotton BA; Podbielski J; Camp E; Welch T; del Junco D; Bai Y; Hobbs R; Scroggins J; Hartwell B; Kozar RA; Wade CE; Holcomb JB;
    Ann Surg; 2013 Oct; 258(4):527-32; discussion 532-3. PubMed ID: 23979267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of blood products for transfusion: is there a best method?
    Devine DV; Serrano K
    Biologicals; 2012 May; 40(3):187-90. PubMed ID: 22119012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
    Anesthesiology; 1996 Mar; 84(3):732-47. PubMed ID: 8659805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Algorithmic and consultative integration of transfusion medicine and coagulation: a personalized medicine approach with reduced blood component utilization.
    Brown RE; Dorion RP; Trowbridge C; Stammers AH; Fitt W; Davis J
    Ann Clin Lab Sci; 2011; 41(3):211-6. PubMed ID: 22075502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Report on notifications pursuant to Section 21 German Transfusion Act for 2007].
    Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jul; 52(7):715-31. PubMed ID: 19572110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method.
    Lu FQ; Kang W; Peng Y; Wang WM
    Transfusion; 2011 Oct; 51(10):2199-207. PubMed ID: 21492181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
    Sandgren P; Callaert M; Shanwell A; Gulliksson H
    Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice.
    Vamvakas EC
    Transfusion; 2013 Apr; 53(4):888-901. PubMed ID: 22882177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood components produced from whole blood using the Atreus processing system.
    Thomas S; Beard M; Garwood M; Callaert M; Waeg Gv; Cardigan R
    Transfusion; 2008 Dec; 48(12):2515-24. PubMed ID: 18774965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative safety of pooled whole-blood-derived platelets prepared by the buffy-coat method versus single-donor (apheresis) platelets.
    Vamvakas EC
    Clin Lab; 2010; 56(7-8):263-79. PubMed ID: 20857891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.